Close Menu
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

PPFAS Asset Management appoints Devendra Ghalsashi as Chief Operating Officer

November 18, 2026

Irfan Pathan and Adah Sharma Grace the Launch of Youth Cricket League’s YCLT10

November 18, 2026

From Military Service to Social Change: Ramesh Sangle Explores Nation-Building in BRIGADE

November 18, 2026
Facebook X (Twitter) Instagram
Trending
  • PPFAS Asset Management appoints Devendra Ghalsashi as Chief Operating Officer
  • Irfan Pathan and Adah Sharma Grace the Launch of Youth Cricket League’s YCLT10
  • From Military Service to Social Change: Ramesh Sangle Explores Nation-Building in BRIGADE
  • Samiran Tea Unveils New Product Portfolio, Including 10 Herbal Tea Blends, at Noida Office Inauguration
  • Manav’s ‘Bardic Voices: Where the Horizon Meets, the Magic Begins’ Explores Memory, Humanity, and the Search for Meaning
  • Glen Industries Limited Reports H1 FY27 Results
  • Spreading Bliss Foundation Supports Children in Orphanage
  • Not Just Another Wellness Brand: How Seltyca Is Combining Doctors, Science and Technology
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World
The Startup StoryThe Startup Story
Home»Health»Perzea Launch Strengthens Hetero Healthcare’s Oncology Leadership Through Partnership with Enzene Biosciences
Health

Perzea Launch Strengthens Hetero Healthcare’s Oncology Leadership Through Partnership with Enzene Biosciences

Arjun SinghBy Arjun SinghSeptember 25, 2025No Comments
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

Hetero Healthcare and Enzene launched Perzea, India’s most affordable Pertuzumab biosimilar

Hyderabad (Telangana) [India], September 25: Hetero Healthcare Limited, in strategic collaboration with Enzene Biosciences, has launched Perzea, India’s most affordable Pertuzumab biosimilar. The introduction of this targeted therapy for HER2-positive breast cancer demonstrates the synergy between two healthcare leaders committed to advanced cancer treatment accessibility.

Innovation Meets Affordability

Pertuzumab plays a vital role in the standard of care for HER2-positive breast cancer worldwide. By leveraging Enzene’s patented EnzeneX technology, Perzea becomes not only affordable but also reliable in terms of quality and production efficiency. This innovation-driven partnership sets new standards for biologics in India.

Speaking on the occasion, Mr. M. Srinivas Reddy, Managing Director of Hetero Healthcare Limited, said:
“At Hetero Healthcare, we believe innovation must be purposeful. With Perzea, we integrate Enzene’s technology with our vision of affordability, ensuring patients in India can access advanced oncology medicines without compromise.”

Strengthening India’s Biopharma Ecosystem

The launch of Perzea highlights India’s growing capabilities in biologics manufacturing and biosimilar development. It also reinforces Hetero Healthcare’s dedication to delivering cutting-edge yet cost-effective therapies across oncology and other therapeutic areas.

About Hetero Healthcare

Hetero Healthcare Limited is recognised for its wide-ranging portfolio in oncology, critical care, and chronic disease management. The company continues to pioneer initiatives that make oncology medicines in India more accessible. Visit: www.heterohealthcare.com

About Enzene Biosciences

Enzene is a next-generation biologics manufacturer and the first to validate a fully connected continuous manufacturing (FCCM™) platform for commercial biologics supply. Its operations in Pune (India) and New Jersey (USA) focus on biologics innovation and affordability. Visit: www.enzene.com

Disclaimer: The article is for general information purposes only and should not be construed as professional medical advice. Always consult your doctor before taking any step.

Health
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
Arjun Singh
  • Website

Related Posts

Continued vigilance is essential to protect India’s polio-free status

November 17, 2026

Apollo Health strengthens its expansion in North India with New Clinic and National Reference Laboratory in Gurugram

November 16, 2026

Aayush Wellness Launches Himalayan Shilajit Drops as Global Shilajit Market is Projected to Reach USD 436.72 Million by 2034, Growing at 8.67% CAGR

November 16, 2026

Comments are closed.

Top Posts

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020

Make your own inhouse library and learn

February 22, 2020

Final Battle – Avengers: Infinity War – Youtube

February 22, 2020
Don't Miss
Business

PPFAS Asset Management appoints Devendra Ghalsashi as Chief Operating Officer

By Arjun SinghNovember 18, 2026

Mr. Devendra Ghalsashi brings over 24 years of experience across mutual funds, AIFs and PMS…

Irfan Pathan and Adah Sharma Grace the Launch of Youth Cricket League’s YCLT10

November 18, 2026

From Military Service to Social Change: Ramesh Sangle Explores Nation-Building in BRIGADE

November 18, 2026

Samiran Tea Unveils New Product Portfolio, Including 10 Herbal Tea Blends, at Noida Office Inauguration

November 18, 2026
Most Popular

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020

Make your own inhouse library and learn

February 22, 2020
Categories
  • Business
  • Business News
  • Education
  • Entertainment
  • Finance
  • Health
  • Lifestyle
  • National
  • Press Release
  • Sports
  • Technology
  • Uncategorized
  • World
Our Picks

PPFAS Asset Management appoints Devendra Ghalsashi as Chief Operating Officer

November 18, 2026

Irfan Pathan and Adah Sharma Grace the Launch of Youth Cricket League’s YCLT10

November 18, 2026

From Military Service to Social Change: Ramesh Sangle Explores Nation-Building in BRIGADE

November 18, 2026

Type above and press Enter to search. Press Esc to cancel.